This analyze proposes that K2's significant adverse impact prevalence is due, at the least in part, to distinctive JWH-018 metabolite activity for the cannabinoid one receptor (CB1R), and suggests that metabolites of most prescription drugs, but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs. -pentanoic https://eam220109642.onesmablog.com/am-2201-fundamentals-explained-71605090